{
    "Case ID": "005239",
    "Different Crime": [
        {
            "Crime Name": "Patent Infringement Dispute",
            "Crime Type": "Economic_Crimes_or_Fraud-related_Offenses",
            "patent_validity": [
                "invalid due to anticipation, obviousness, lack of utility"
            ],
            "applicable_statute": [
                "Canadian Patent Law"
            ],
            "expert_testimony": [
                "submitted"
            ],
            "evidence_provided": [
                "WO371 disclosed similar particle sizes",
                "common knowledge included dosage ranges",
                "utility claims lacked substantiation",
                "'about' was narrowly interpreted"
            ],
            "decision_outcome": [
                "application dismissed",
                "allowing Apotex to proceed with its generic product"
            ],
            "cause_of_action": [
                "patent infringement"
            ],
            "nature_of_offense": [
                "anticipation",
                "obviousness",
                "lack of utility"
            ],
            "mitigating_factors": [
                "costs were awarded to Apotex but reduced due to dropped allegations"
            ]
        }
    ]
}